CAIRO: Egyptian drug maker EIPICO’s 2011 first-half net profit rose 1.8 percent year-on-year to LE 182 million ($30.5 million), the stock exchange said.
Net profit for the same period in 2010 was LE 178.7 million. The firm has a capital of LE 793.4 million divided into 79.3 million shares, each at a nominal value of LE 10.
